Rhinomed (ASX:RNO) Inventories, Finished Goods : A$1.45 Mil (As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Inventories, Finished Goods?

Rhinomed's quarterly finished goods declined from Jun. 2022 (A$1.19 Mil) to Dec. 2022 (A$0.00 Mil) but then increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$1.45 Mil).

Rhinomed's annual finished goods increased from Jun. 2021 (A$0.12 Mil) to Jun. 2022 (A$1.19 Mil) and increased from Jun. 2022 (A$1.19 Mil) to Jun. 2023 (A$1.45 Mil).

Rhinomed Inventories, Finished Goods Historical Data

The historical data trend for Rhinomed's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Inventories, Finished Goods Chart

Rhinomed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.21

0.32

0.12

1.19

1.45

Rhinomed Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Inventories, Finished Goods	Get a 7-Day Free Trial															0.12	-	1.19	-	1.45

Rhinomed Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Rhinomed (ASX:RNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

RHNMF:USA

Address

132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121

Website

https://www.rhinomed.global

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines